Legal Opinion
Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals LP
Court of Appeals for the Federal Circuit
Decided December 1, 2011No. 2011-1091PublishedCited by 32 opinions
1Opinion of the Court
LINN, Circuit Judge.
Teva Pharmaceutical Industries Ltd. (“Teva”) appeals from the Eastern District of Pennsylvania’s entry of summary judgment in favor of AstraZeneca Pharmaceuticals LP and IPR Pharmaceuticals Inc. (collectively “AstraZeneca”) invalidating claims 1, 26, 42, and 52 (“asserted claims”) of Teva’s U.S. Patent No. RE39,502 (“'502 patent”) based on AstraZeneca’s prior invention of the subject matter claimed therein. Because the district court correctly concluded that AstraZeneca’s earlier development of the accused CRESTOR® drug (“AstraZeneca’s drug”) formulation satisfied the…
2Cases cited13 opinions
- Burroughs Wellcome Co. v. Barr Laboratories, Inc., and Novopharm, Inc. And Novopharm, Ltd.Court of Appeals for the Federal Circuit · 1994
- Azur v. Chase Bank, USA, National Ass'nCourt of Appeals for the Third Circuit · 2010
- Invitrogen Corp. (Formerly Known as Life Technologies, Inc.) v. Clontech Laboratories, Inc.Court of Appeals for the Federal Circuit · 2005
- Peter B. Cooper v. David GoldfarbCourt of Appeals for the Federal Circuit · 1998
- In Re Huai-Hung KaoCourt of Appeals for the Federal Circuit · 2011
8 more not listed; retrieve them via the Exa API.
3Cited by32 opinions
- Accenture Global Services v. Guidewire Software, Inc.Court of Appeals for the Federal Circuit · 2013
- Taurus IP, LLC v. Daimlerchrysler Corp.Court of Appeals for the Federal Circuit · 2013
- SkinMedica, Inc. v. Histogen Inc.Court of Appeals for the Federal Circuit · 2013
- Howmedica Osteonics Corp. v. Zimmer, Inc.Court of Appeals for the Federal Circuit · 2016
- Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2013
27 more not listed; retrieve them via the Exa API.